Development of an isogenic human cell trio that models polyglutamine disease

This study thus demonstrates the potential of UKiS, which is a beneficial platform for the efficient development of cell models not only for polyQ diseases but also for any other genetic diseases, which may accelerate our deeper understanding of disease mechanisms and cell-based screening for therapeutic drugs.PMID:37821389 | DOI:10.1266/ggs.22-00030
Source: Genes and Genetic Systems - Category: Genetics & Stem Cells Authors: Source Type: research
More News: Ataxia | Brain | Genetics | Neurology | Study